AU2002259114A1 - Preparation of paroxetine involving novel intermediates - Google Patents

Preparation of paroxetine involving novel intermediates

Info

Publication number
AU2002259114A1
AU2002259114A1 AU2002259114A AU2002259114A AU2002259114A1 AU 2002259114 A1 AU2002259114 A1 AU 2002259114A1 AU 2002259114 A AU2002259114 A AU 2002259114A AU 2002259114 A AU2002259114 A AU 2002259114A AU 2002259114 A1 AU2002259114 A1 AU 2002259114A1
Authority
AU
Australia
Prior art keywords
paroxetine
preparation
novel intermediates
involving novel
involving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002259114A
Inventor
Ilya Avrutov
Gideon Pilarski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Industries Ltd
Original Assignee
Teva Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd filed Critical Teva Pharmaceutical Industries Ltd
Publication of AU2002259114A1 publication Critical patent/AU2002259114A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2002259114A 2002-02-22 2002-05-01 Preparation of paroxetine involving novel intermediates Abandoned AU2002259114A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35891602P 2002-02-22 2002-02-22
US60/358,916 2002-02-22
PCT/US2002/013826 WO2003072104A1 (en) 2002-02-22 2002-05-01 Preparation of paroxetine involving novel intermediates

Publications (1)

Publication Number Publication Date
AU2002259114A1 true AU2002259114A1 (en) 2003-09-09

Family

ID=79169877

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002259114A Abandoned AU2002259114A1 (en) 2002-02-22 2002-05-01 Preparation of paroxetine involving novel intermediates

Country Status (6)

Country Link
EP (1) EP1482939A4 (en)
JP (1) JP2005524656A (en)
AU (1) AU2002259114A1 (en)
CA (1) CA2476723A1 (en)
IL (1) IL163593A0 (en)
WO (1) WO2003072104A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010260826A (en) * 2009-05-08 2010-11-18 Sumitomo Chemical Co Ltd Method of manufacturing paroxetine hydrochloride semihydrate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2058061T3 (en) * 1985-10-25 1994-11-01 Beecham Group Plc DERIVED FROM PIPERIDINE, ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT.
AR001982A1 (en) * 1995-02-06 1998-01-07 Smithkline Beecham Plc PAROXETINE CHLORHYDRATE ANHYDRATED, AND PROCEDURE FOR ITS PREPARATION
JP3882224B2 (en) * 1996-05-31 2007-02-14 旭硝子株式会社 Method for producing paroxetine
GB9726907D0 (en) * 1997-12-19 1998-02-18 Smithkline Beecham Plc Novel compounds
GB9914583D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel process
JP2001139572A (en) * 1999-11-17 2001-05-22 Sumika Fine Chemicals Co Ltd Method for producing anhydrous paroxetinic hydrochloride 2-propanol solvate

Also Published As

Publication number Publication date
EP1482939A1 (en) 2004-12-08
CA2476723A1 (en) 2003-09-04
JP2005524656A (en) 2005-08-18
IL163593A0 (en) 2005-12-18
WO2003072104A1 (en) 2003-09-04
EP1482939A4 (en) 2005-10-12

Similar Documents

Publication Publication Date Title
AU2003230192A1 (en) Novel crystalline forms of aripiprazole
AU2003245572A1 (en) Preparation of chiral amino-nitriles
AU2003255982A1 (en) Preparation of microcapsules
AU2003217105A1 (en) Novel of cytokine inhibitors
AU2003277596A1 (en) Method of deuterization
AU2003206803A1 (en) Production of alkenones
AU2003268687A1 (en) Novel salt of 2-acylaminothiazole derivative
AU2002305162A1 (en) Polymorphs of fexofenadine hydrochloride
AUPS096002A0 (en) Method of construction
WO2005033343A8 (en) Novel splice variants of human dkkl1
AU2003219580A1 (en) Novel therapeutical use of byakangelicin
AU2003265373A1 (en) Preparation of aztreonam
AU2003216848A1 (en) Deracemisation of amines
AU2003282162A1 (en) Novel adhesives comprising diacetals
AU2003298725A1 (en) Preparation of metallotexaphyrins
AU2003229459A1 (en) Methods of using thiazolidinedithione derivatives
AU2002259114A1 (en) Preparation of paroxetine involving novel intermediates
AU2003229611A1 (en) Preparation of substituted indenes
AU2003238034A1 (en) Novel use of imidazotriazinones
AU2003239773A1 (en) Preparation of vaccines
AU2003262704A1 (en) Synthesis of gatifloxacin
AU2003299746A1 (en) Total synthesis of daurichromenic acid
AU2003255810A1 (en) Construction of lampshades
AU2003240450A1 (en) Manufacture of ketopantolactone
AU2003280396A1 (en) Preparation of substituted indenes

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase